Issue of Securities

Company Announcement 2 September, 2019
TruScreen Share Placement
ISSUE OF SECURITIES BY
TRUSCREEN LIMITED (TRU)
TruScreen Limited advises that it has issued new shares and options as follows:
Class of Security:
Ordinary Shares (TRU)
Unlisted options (TRUOA)
Number issued:
1,000,000 ordinary shares (TRU) at NZD 10.6 cents each fully paid
1,000,000 unlisted options (TRUOA)exercisable at 13 cents per share
before 12 July 2021
Payment: Cash on subscription
Percentage of total Class
of Securities issued:
TRU
0.4% (of the total number of ordinary shares on issue post
completion of the issue)
TRUOA 9.4% (of the total number of unlisted share options on issue
post completion of the issue)
Reason for the issue: Participation in share placement
Authority of issue: Approved by shareholders at Annual Meeting held on 27 August 2019
Resolution 8.
Terms of issue: The new shares are credited as fully paid, and rank in all
respects equally with the shares already on issue.
The unlisted share options are exercisable at 13 cents per share
before 12 July 2021
Total number of securities
of the Class in existence
after the issue:
TRU
227,534,804
TRUOA 10,677,363
Date of issue: 30 August, 2019

TRUSCREEN LIMITED
Guy Robertson
Chief Financial Officer
-ENDS-
For more information visit www.truscreen.com or contact Guy Robertson, TruScreen Chief Financial
Officer, email: guyrobertson@truscreen.com
About TruScreen:
TruScreen’s real time cervical cancer
technology utilises a digital wand which is
placed on the surface of the cervix to measure
electrical and optical signals from the
surrounding tissue. A sophisticated proprietary
algorithm framework distinguishes between
normal and abnormal (cancerous and
precancerous) tissue to identify precancerous
change, or cervical intraepithelial neoplasia
(CIN). A Single Use Sensor (SUS) is used for
each patient to protect against cross-infection.